about
Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in SwedenMetabolic Profiling of Chicken Embryos Exposed to Perfluorooctanoic Acid (PFOA) and Agonists to Peroxisome Proliferator-Activated ReceptorsAnalytical challenges hamper perfluoroalkyl research.Comparison of PFASs contamination in the freshwater and terrestrial environments by analysis of eggs from osprey (Pandion haliaetus), tawny owl (Strix aluco), and common kestrel (Falco tinnunculus).Recent developments in trace analysis of poly- and perfluoroalkyl substances.Temporal trends of PFSAs, PFCAs and selected precursors in Australian serum from 2002 to 2013.Levels of 12 perfluorinated chemicals in pooled australian serum, collected 2002-2003, in relation to age, gender, and region.Polyfluorinated telomers in precipitation and surface water in an urban area of Japan.The effect of drinking water contaminated with perfluoroalkyl substances on a 10-year longitudinal trend of plasma levels in an elderly Uppsala cohort.Perfluoroalkyl acids in subarctic wild male mink (Neovison vison) in relation to age, season and geographical area.Changes in serum levels of perfluoroalkyl substances during a 10-year follow-up period in a large population-based cohort.Perfluoroalkyl substances (PFAS) including structural PFOS isomers in plasma from elderly men and women from Sweden: Results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS).Transcription of genes involved in fat metabolism in chicken embryos exposed to the peroxisome proliferator-activated receptor alpha (PPARα) agonist GW7647 or to perfluorooctane sulfonate (PFOS) or perfluorooctanoic acid (PFOA).Role of peroxisome proliferator-activated receptor-alpha in hepatobiliary injury induced by ammonium perfluorooctanoate in mouse liver.A time trend study of significantly elevated perfluorocarboxylate levels in humans after using fluorinated ski wax.Biotransformation of fluorotelomer compound to perfluorocarboxylates in humans.Professional ski waxers' exposure to PFAS and aerosol concentrations in gas phase and different particle size fractions.Development of a solid-phase extraction-HPLC/single quadrupole MS method for quantification of perfluorochemicals in whole blood.Increasing levels of long-chain perfluorocarboxylic acids (PFCAs) in Arctic and North Atlantic marine mammals, 1984-2009.Biomonitoring perfluorinated compounds in Catalonia, Spain: concentrations and trends in human liver and milk samples.Relationship between dietary exposure and serum perfluorochemical (PFC) levels--a case study.Case-control study on perfluorinated alkyl acids (PFAAs) and the risk of prostate cancer.Perfluorinated chemicals in relation to other persistent organic pollutants in human blood.Occurrence of brominated dioxins in a study using various firefighting methods.Contribution of precursor compounds to the release of per- and polyfluoroalkyl substances (PFASs) from waste water treatment plants (WWTPs).A rapid method for the determination of perfluoroalkyl substances including structural isomers of perfluorooctane sulfonic acid in human serum using 96-well plates and column-switching ultra-high performance liquid chromatography tandem mass spectroIdentification and pattern of perfluorooctane sulfonate (PFOS) isomers in human serum and plasma.Accuracy and precision in the determination of perfluorinated chemicals in human blood verified by interlaboratory comparisons.Changes in plasma levels of perfluoroalkyl substances (PFASs) are related to increase in carotid intima-media thickness over 10 years - a longitudinal study.Peer Reviewed: Analytical Challenges Hamper Perfluoroalkyl ResearchHuman Exposure to Perfluorinated Compounds in Catalonia, Spain: Contribution of Drinking Water and Fish and ShellfishExposure to perfluorinated compounds in Catalonia, Spain, through consumption of various raw and cooked foodstuffs, including packaged foodAssociation of Exposure to Persistent Organic Pollutants With Mortality Risk: An Analysis of Data From the Prospective Investigation of Vasculature in Uppsala Seniors (PIVUS) Study
P50
Q24676545-AEFCD950-B130-40FE-A8C0-340175C18C17Q28551209-615B4E60-AD1A-4043-9588-7EAD13FE42B1Q35856711-C4A2F479-CDC2-437E-9664-CEA1C5184CF0Q36016555-312A370D-FD89-41FE-AF1E-80B0A27A728DQ37852614-D1BC302A-1764-4186-A6A1-794765D4B341Q39303037-FE57E2F0-ADB8-4CE1-AD10-F28FCD323ABDQ39761709-9824D4FD-BD8A-43EB-87F9-C615D9B1FF7CQ39865978-E0F2B941-FB75-4FCD-92B0-7D82E899882CQ40093585-92D651C7-3E00-4423-97F9-FB301613F544Q40129752-54FCA0BC-8A33-46CF-9083-BA7073550349Q40614790-4A5BF631-BCAE-41E4-9C4D-42A8E3D83F20Q41722218-BA1F368D-82CB-4FE4-B3E5-58AA221B7002Q42719530-B9FC4E4E-6638-4282-AA9B-555FD0463D1AQ43160113-BCC9DD07-AA4B-4E98-86A7-88C89C5557F1Q43160974-783F186D-94F4-409B-9EF9-5A49A035A439Q43640783-A94148D1-E401-4DC9-9F83-E2EC1BA0AC9AQ44284911-F454CF61-45C6-41F2-B2B0-452682EB564EQ45243460-8EBADD63-5107-44F3-A5D2-51D8D933CA05Q45721662-F8DEA6E5-9B22-45BF-9E5E-37A43B201590Q46002896-19EA1A2F-9684-43CA-9AD0-072082585074Q46105326-CA73F57C-680D-4734-AA81-9CD98C6BA83AQ46632750-DB0E8C0B-E8B7-4526-9773-9D634FF0283CQ46887370-6679F565-7B85-4EDA-8E76-7017E0B3E8A9Q47688316-A2288576-9757-439D-A065-8348B5A558FDQ47775098-A529157F-304E-4CAB-9CD5-83D704A43E32Q47923835-F42DA629-9500-4FDA-B8DD-E319E07A6FF2Q50775588-DC19AEB1-B8DF-4A86-969F-33F16034010BQ53204901-4B2669C8-A715-4BBD-8116-A98A43D490B4Q55517871-CC9FD00A-6232-457E-AC0D-5C6F1876244CQ57158333-BFB90A55-7B6D-48E0-8201-E26F44EDB2C1Q57266469-880A29C9-EC39-40D9-9E18-A8E51A1E502FQ57266507-94273D3C-F75F-4E82-A8A1-364FEFA9993EQ64086121-D59FB9D5-E469-490C-9D7B-1AC8ADBBE0B8
P50
name
Anna Kärrman
@en
Anna Kärrman
@nl
type
label
Anna Kärrman
@en
Anna Kärrman
@nl
prefLabel
Anna Kärrman
@en
Anna Kärrman
@nl